In one paragraphArticle in mSystems, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
11 authors.
Carlismari O GrundmannDepartment of Chemistry and Biochemistry, University of California Santa Cruz (UCSC), Santa Cruz, California, USA.ORCID 0000-0003-2799-3527 Weilan G P MeloSchool of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo (FCFRP-USP), Ribeirão Preto, São Paulo, Brazil.ORCID 0000-0002-3097-1487 Andrés M Caraballo RodríguezSkaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego (UCSD), San Diego, California, USA.ORCID 0000-0001-5499-2728 Nina U de A GuardiaSchool of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo (FCFRP-USP), Ribeirão Preto, São Paulo, Brazil.
Ivan L F MiglioriniSchool of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo (FCFRP-USP), Ribeirão Preto, São Paulo, Brazil.ORCID 0000-0002-9515-383X Ricardo R Da SilvaSchool of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo (FCFRP-USP), Ribeirão Preto, São Paulo, Brazil.
Pieter C DorresteinSkaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego (UCSD), San Diego, California, USA.
Norberto P LopesSchool of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo (FCFRP-USP), Ribeirão Preto, São Paulo, Brazil.ORCID 0000-0002-8159-3658 Jon ClardyDepartment of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts, USA.ORCID 0000-0003-0213-8356 Mônica T PupoSchool of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo (FCFRP-USP), Ribeirão Preto, São Paulo, Brazil.ORCID 0000-0003-2705-0123 Funding
Conselho Nacional de Desenvolvimento Científico e Tecnológico 303792/2018-2, 307893/2022-7Coordenação de Aperfeiçoamento de Pessoal de Nível Superior Finance code 001Fundação de Amparo à Pesquisa do Estado de São Paulo 2013/50954-0, 2013/07600-3, 2020/06430-0, 2019/06061-8, 2015/01001-6, 2016/17614-0, 2025/03943-0, 2020/02207-5Gordon and Betty Moore Foundation GBMF12120
6 · The paper itselfAbstract
Fungus-growing ants engage in a multipartite symbiosis, including
Indexed as
AntsMetabolomePseudonocardiaSymbiosisAnimalsHypocrealesMetabolomicsPhylogenyRNA, Ribosomal, 16SRNA, Ribosomal, 16Schemical ecologychemical profilesEscovopsismicrobial interactionsPseudonocardiasecondary metabolitesspecialized metabolites
Identifiers
PMID41891714
PMCPMC13098279
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390